Durata Therapeutics, Inc.
DelistedCIK 1544116fmd_0HZMJ0MBW6Q4VDA4Y3WQ45MEG6Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2014, 16 periods
Latest annual · FY2013
Millions- Operating income
- (57)
- Net income
- (62)
- Free cash flow
- (61)
Latest quarter · Q3 FY2014
Millions- Total revenues
- 10
- Gross profit
- 10
- Operating income
- (18)
- Net income
- (20)
Durata Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2013 | FY2012 | Change | Source |
|---|---|---|---|---|
| Operating income | -$57 million | -$62.6 million | 10-K 2014-03-14 · proof | |
| Net income | -$62.1 million | -$62.5 million | 10-K 2014-03-14 · proof | |
| Cash from operating activities | -$60.8 million | -$58 million | 10-K 2014-03-14 · proof | |
| Free cash flow | -$61.3 million | -$58.7 million | 10-K 2014-03-14 · proof | |
| Total assets | $100.1 million | $86.5 million | +15.7% | 10-K 2014-03-14 · proof |
| Total liabilities | $61.6 million | $42.7 million | +44.3% | 10-K 2014-03-14 · proof |
| Cash and cash equivalents | $36.9 million | $32.3 million | +14.2% | 10-K 2014-03-14 · proof |
- What was Durata Therapeutics, Inc.'s operating income in fiscal 2013?
- Durata Therapeutics, Inc. reported operating income of -$57 million for fiscal 2013 (the year ended Dec 31, 2013), against -$62.6 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2014. SEC
- What was Durata Therapeutics, Inc.'s net income in fiscal 2013?
- Durata Therapeutics, Inc. reported net income of -$62.1 million for fiscal 2013 (the year ended Dec 31, 2013), against -$62.5 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2014. SEC
- What was Durata Therapeutics, Inc.'s cash from operating activities in fiscal 2013?
- Durata Therapeutics, Inc. reported cash from operating activities of -$60.8 million for fiscal 2013 (the year ended Dec 31, 2013), against -$58 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2014. SEC
- What was Durata Therapeutics, Inc.'s free cash flow in fiscal 2013?
- Durata Therapeutics, Inc. reported free cash flow of -$61.3 million for fiscal 2013 (the year ended Dec 31, 2013), against -$58.7 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2014. SEC
- What are Durata Therapeutics, Inc.'s total assets?
- As of Dec 31, 2013, Durata Therapeutics, Inc. reported total assets of $100.1 million, against $86.5 million a year earlier (+15.7%). Source: the 10-K filed with the SEC on Mar 14, 2014. SEC
- What are Durata Therapeutics, Inc.'s total liabilities?
- As of Dec 31, 2013, Durata Therapeutics, Inc. reported total liabilities of $61.6 million, against $42.7 million a year earlier (+44.3%). Source: the 10-K filed with the SEC on Mar 14, 2014. SEC
- What are Durata Therapeutics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2013, Durata Therapeutics, Inc. reported cash and cash equivalents of $36.9 million, against $32.3 million a year earlier (+14.2%). Source: the 10-K filed with the SEC on Mar 14, 2014. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1544116&period_type=annual&limit=5"Information only, not investment advice.